The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArmadale Capital Regulatory News (ACP)

Share Price Information for Armadale Capital (ACP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.725
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.05 (7.143%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.725
ACP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding and TVR

11 Mar 2022 14:45

RNS Number : 5474E
Armadale Capital PLC
11 March 2022
 

 

Armadale Capital Plc / Index: AIM / Epic: ACP / Sector: Investment Company

 

11 March 2022

 

 

Armadale Capital Plc

('Armadale' or 'the Company')

 

Director/PDMR Shareholding and TVR

 

 

Armadale Capital plc, the AIM quoted investment group focused on natural resource projects in Africa, announces that it has received from Matt Bull, a director, an exercise notice for 7,852,273 warrants to subscribe for ordinary shares of 0.1 pence each in the capital of the Company ("Ordinary Shares"), at an exercise price of 2.2 pence per Ordinary Share, raising £172,750. Accordingly, pursuant to the block admission arrangements announced on 18 June 2020 and 28 June 2021, it has issued 7,852,273 Ordinary Shares to Mr Bull which rank pari passu with the Company's existing Ordinary Shares.

Following the issue of these new Ordinary Shares, the Company's total issued share capital consists of 548,193,824 Ordinary Shares with no shares held in Treasury. This figure may be used as the denominator for the calculations by which shareholders can determine if they are required to notify their interest in, or a change to their interest in, the Company.

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain. 

 

 

 

Enquiries:

Armadale Capital Plc

Nick Johansen, Chairman

Tim Jones, Company Secretary

+44 (0) 20 7236 1177

Nomad and broker: finnCap Ltd

Christopher Raggett / Seamus Fricker / Teddy Whiley

+44 (0) 20 7220 0500

 

 

Notes

Armadale's wholly-owned Mahenge Liandu Graphite Project is located in a highly prospective region, with a high-grade JORC compliant indicated and inferred mineral resource estimate announced February 2018 - 59.5Mt at 9.8% TGC. This includes 11.5Mt @ 10.5% Measured 32.Mt Indicted at 9.6% and 15.9Mt at 9.8% TGC, making it one of the largest high-grade resources in Tanzania.

The work to date has demonstrated the Project's potential as a commercially viable deposit, with significant tonnage, high-grade coarse flake and near surface mineralisation (implying a low strip ratio) contained within one contiguous ore body.

The Company's updated Definitive Feasibility Study (June 2020) confirmed Mahenge as a long-life low-cost graphite project with a US$430m NPV and IRR of 91% based on a two-stage expansion strategy comprising:

· Stage One - processing plant and infrastructure at a nominal design basis rate of 0.4-0.5 Mt/pa to produce a nominal 60,000t/pa graphite concentrate in the first three years of production

· Stage Two - a second 0.5 Mt/y plant and associated additional infrastructure doubling throughput to 1 Mt/y from Year 5 of operation

The DFS shows that Armadale can be a significant low-cost supplier to the graphite industry with the potential to generate pre-tax cashflows of US$985m over an initial 15 year mine-life and scope for further improvement as this utilises just 25% of the current resource, which remains open in multiple directions.

Projected timeline to first production is expected to be approximately 10-12 months from the start of construction and the capital cost estimate for Stage 1 is US$39.7m, which includes a contingency of U$S4.1m or 15% of total direct capital cost, with a 1.6 year payback for Stage 1 (after tax) based on an average sales price of US$1,112/t. Stage 2 expansion is expected to be funded from cashflow.

More information can be found on the website www.armadalecapitalplc.com.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them are set out below pursuant to the EU Market Abuse regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Matthew Bull

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Technical Director & Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Armadale Capital plc

b)

 

LEI

 

213800495EK876JETD10

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

0.1p Ordinary Shares

 

 

ISIN: GB00BYMSY631

 

b)

 

Nature of the transaction

 

 Exercise of warrants

 

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

2.2p

7,852,273

d)

 

Aggregated information

- Aggregated volume

- Price

N/A

 

 

e)

 

Date of the transaction

 

11 March 2022

f)

 

Place of the transaction

 

Outside a trading venue

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFVSVEILLIF
Date   Source Headline
28th Sep 20107:00 amBUSHalf-yearly Report
9th Sep 20107:00 amBUSIssue of Equity
13th Aug 20108:52 amBUSDirectorate Change
21st Jul 201010:22 amBUSResult of AGM
30th Jun 20104:07 pmBUSResult of AGM
29th Jun 20107:00 amBUSFinal Results 2009
23rd Jun 20102:50 pmBUSFurther re Placing
7th Jun 201010:00 amBUSNotice of AGM
28th May 201012:34 pmBUSHolding(s) in Company
28th May 201011:04 amBUSIssue of Equity
26th May 20107:00 amBUSProposed Placing
14th May 20108:40 amBUSProject Update
21st Apr 201012:15 pmBUSClarification
20th Apr 201010:56 amBUSProject Update
21st Dec 20097:00 amBUSWatermark: Final Scoping Report Approval
7th Dec 20097:00 amBUSRe Agreement
2nd Dec 20092:32 pmBUSHolding(s) in Company
19th Nov 200910:50 amBUSCompany Update
30th Oct 20097:00 amBUSCompany update
7th Oct 20094:10 pmBUSHolding(s) in Company
7th Oct 200910:24 amBUSHolding(s) in Company
5th Oct 20097:00 amBUSInformation Update
29th Sep 20091:59 pmBUSHolding(s) in Company
25th Sep 20091:34 pmBUSHolding(s) in Company
22nd Sep 20093:44 pmBUSHolding(s) in Company
3rd Sep 20092:28 pmBUSIssue of Equity
1st Sep 20097:30 amBUSIssue of Equity
1st Sep 20097:00 amBUSHalf-yearly Report
7th Aug 200910:39 amBUSResource Verification
24th Jul 200911:22 amBUSAGM Statement
30th Jun 200912:04 pmBUSFinal Results
23rd Jun 20094:33 pmBUSHolding(s) in Company
23rd Jun 20091:57 pmBUSHolding(s) in Company
15th Jun 200911:28 amBUSResult of EGM
20th May 20093:33 pmBUSIssue of Equity
17th Mar 20099:10 amBUSIssue of Equity
19th Feb 200911:56 amBUSConclusion of Funding Arrangement with the Development Bank of South Africa ("DBSA")
13th Jan 200911:38 amBUSRe Agreement
13th Oct 20087:00 amRNSPilot Plant Production Results
9th Oct 200810:30 amRNSIssue of Equity
25th Sep 20085:16 pmRNSHolding(s) in Company
5th Sep 200810:10 amRNSHolding(s) in Company
2nd Sep 20084:45 pmRNSHolding(s) in Company
29th Aug 20087:00 amRNSInterim Results
27th Aug 200810:00 amRNSIssue of Equity
27th Aug 20088:00 amRNSDirectorate Change
8th Jul 200810:22 amRNSTotal Voting Rights
30th Jun 20087:00 amRNSAGM statement, Directors deal
12th Jun 20085:33 pmRNSAnnual Report and Accounts
30th May 200811:17 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.